Ad copy

Methylene blue–based photodynamic therapy may represent a smarter, context-dependent approach to cancer treatment—one that leverages selective vulnerability rather than maximal toxicity—highlighting a shift toward precision-driven strategies that target tumor-specific weaknesses while minimizing collateral damage to healthy tissue.